Optima: A phase II dose and volume de-escalation trial for high- and low-risk HPV+ oropharynx cancers.
Year: 2017
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: James Melotek, Tanguy Y. Seiwert, Elizabeth A. Blair, Theodore G. Karrison, Nishant Agrawal, Louis Portugal, Zhen Gooi, Kerstin Stenson, Ryan J. Brisson, Saba Arshad, Allison Dekker, Sara Kochanny, Vassiliki Saloura, Michael T. Spiotto, Victoria Meucci Villaflor, Daniel J. Haraf, Everett E. Vokes
Language: English
Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2892045530